Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetylserotonin O-methyltransferase-like protein (ASMTL) is a bifunctional enzyme encoded by the ASMTL gene, located in the pseudoautosomal region of the X and Y chromosomes in humans. It possesses two distinct functional domains: an N-terminal domain homologous to bacterial Maf proteins and a C-terminal domain similar to N-acetylserotonin O-methyltransferase (ASMT). ASMTL hydrolyzes dTTP and UTP (and to a lesser extent other nucleotides), suggesting a role in nucleotide metabolism and potentially in preventing the incorporation of modified nucleotides into nucleic acids. Although its C-terminal domain implies possible methyltransferase activity, direct enzymatic activity for N-acetylserotonin methylation by ASMTL is not well established in contrast to its paralog ASMT. ASMTL is expressed in various tissues, where it may regulate cell division and nucleotide pool balance. Its precise physiological function and disease associations are still under investigation[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylserotonin O-methyltransferase-like protein (ASMTL).